Table 2: Effect of C. asiatica on physical fitness measured by 30-s chair stand test and 6-min walk test.

ItemsPre-dose baseline scorePost-dose score
1 month2 month3 monthDelay

30-s chair stand test (times)
Placebo15.85 ± 2.8715.65 ± 2.8015.70 ± 2.99 , ,
CA25016.85 ± 4.2118.40 ± 4.0718.35 ± 4.85 , ,
CA50016.80 ± 4.3617.75 ± 3.80 , ,
CA75016.80 ± 3.0917.45 ± 3.53 , ,

6 min walk test (meters)
Placebo515.60 ± 42.18509.45 ± 55.78504.95 ± 57.32
CA250517.60 ± 59.75527.95 ± 42.34524.25 ± 49.77
CA500509.50 ± 57.38517.00 ± 64.62523.10 ± 67.8 ,
CA750511.75 ± 54.12517.80 ± 75.67529.05 ± 82.27

Subjects were measured physical fitness measured by 30-s chair stand test and 6-min walk test. Data are presented as mean ± SD. - and -values were compared between pre-dose baseline score and post-dose 1, 2, 3 month and 1 month after cessation of treatment ( = 20/group). -value <.01 and.001 compared with pre-dose baseline score, respectively.
*, **, -value , and compared with placebo treated group, respectively.